$VIPZ Balance Sheet | Understand Stock

$VIPZ

$0.34 -$0.01 (2.86%) Close

$VIPZ Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2026 As of Jun 30, 2026	Q3 FY2026 As of Mar 31, 2026	Q2 FY2026 As of Dec 31, 2025	Q1 FY2026 As of Sep 30, 2025	Q4 FY2025 As of Jun 30, 2025	Q3 FY2025 As of Mar 31, 2025	Q2 FY2025 As of Dec 31, 2024	Q1 FY2025 As of Sep 30, 2024	Q4 FY2024 As of Jun 30, 2024	Q3 FY2024 As of Mar 31, 2024	Q2 FY2024 As of Dec 31, 2023	Q1 FY2024 As of Sep 30, 2023	Q4 FY2023 As of Jun 30, 2023	Q3 FY2023 As of Mar 31, 2023	Q2 FY2023 As of Dec 31, 2022	Q1 FY2023 As of Sep 30, 2022	Q4 FY2022 As of Jun 30, 2022	Q3 FY2022 As of Mar 31, 2022	Q2 FY2022 As of Dec 31, 2021	Q1 FY2022 As of Sep 30, 2021
ASSETS
Current assets:
Cash
Prepaid expenses
Cash reserved for users
Related party receivables
Prepaid expenses and other current assets
Discontinued operations - current assets
Total current assets

Equipment, net
Intangible assets, net
Goodwill
Debt issuance costs, net
Deposits and other assets
Total other assets
Related party note receivable
Security deposit
Total assets

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued expenses
Accounts payable and accrued expenses - related party
Accrued expenses - related party
Players balances
Accrued expenses, related parties, current
Notes payable - related party
Notes payable
Related Party
Nonrelated Party
Convertible promissory notes
Related Party
Total convertible promissory notes
Line of credit - related party
Related Party
Total line of credit - related party
Derivative liability
Discontinued operations - current liabilities
Total current liabilities

Notes payable - long-term
Total liabilities
Preferred Stock Series A, Value
Preferred Stock Series B, Value
Preferred Stock Series C, Value
Series B preferred stock, 12,000 shares designated, 11,693 and 11,693 shares issued and outstanding as of June 30, 2026, and June 30, 2025, respectively
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Total series B preferred stock, 12,000 shares designated, 11,693 and 11,693 shares issued and outstanding as of June 30, 2026, and June 30, 2025, respectively

Common stock, $0.001 par value, 475,000,000 shares authorized, 73,457,857 and 73,457,857 shares issued and outstanding as of June 30, 2026, and June 30, 2025, respectively
Additional paid-in capital
Subscriptions receivable
Accumulated deficit
Stockholders' deficit
Series C Preferred Stock
Total stockholders' deficit
Total stockholders’ deficit
Total liabilities and stockholders’ deficit

Comments